Skip to main content

Table 2 Direct medical costs for patients with Ischaemic heart disease, Ischaemic and Haemorrhagic stroke and Hypertensive heart disease stratified by resource use for the two study hospitals

From: Estimation and determinants of direct medical costs of ischaemic heart disease, stroke and hypertensive heart disease: evidence from two major hospitals in Cameroon

  IHD
n = 92
I-stroke
n = 317
H-stroke
n = 193
HHD
n = 248
Overall
N = 850
Consultation
Mean (SD) 6300 (5200) 13,700 (9800) 10,400 (7300) 7400 (7400) 10,300 (8700)
[11.4 (9.4)] [24.8 (17.7)] [18.8 (13.2)] [13.4 (13.4)] [18.6 (15.7)]
Median (25th – 75th percentile) 3500 (3500 – 7000) 7000 (7000 – 21,000) 7000 (7000 – 14,000) 7000 (3500 – 7000) 7000 (3500 – 14,000)
[6.3 (6.3–12.7)] [12.7 (12.7–38.0)] [12.7 (12.7–25.3)] [12.7 (6.3–12.7)] [12.7 (6.3–25.3)]
Sum (% of total costs) 577,500 (0.5) 4,336,500 (1.5) 2,009,000 (1.3) 1,841,000 (1.9) 8,764,000 (1.2)
[1045.4] [7849.7] [3636.6] [3332.5] [15,864.2]
Laboratory tests
Mean (SD) 96,300 (58,700) 111,000 (74,300) 100,300 (80,900) 102,700 (109,600) 104,500 (86,000)
[174.3 (106.3)] [200.9 (134.5)] [181.5 (146.4)] [185.9 (198.4)] [189.1 (155.6)]
Median (25th – 75th percentile) 67,700 (63,400–131,300) 103,900 (55,000–144,900) 82,100 (49,700–126,200) 58,300 (20,300 – 150,400) 85,800 (41,100 – 140,800)
[122.5 (114.7–237.7)] [188.0 (99.5–262.3)] [148.6 (89.9–228.4)] [105.5 (36.7–272.2)] [155.3 (74.4–254.8)]
Sum (% of total costs) 8,856,500 (6.9) 34,646,800 (11.7) 19,258,600 (12.2) 24,742,700 (25.9) 87,504,600 (12.9)
[16,031.6] [62,715.9] [34,860.9] [44,788.0] [158,396.5]
Imaging & procedures
Mean (SD) 1,072,000 (1,356,000) 193,300 (115,600) 192,000 (317,700) 74,800 (124,900) 262,000 (575,600)
[1940.4 (2454.5)] [349.9 (209.2)] [347.5 (575.1)] [135.4 (226.1)] [474.2 (1041.9)]
Median (25th – 75th percentile) 675,000 (61,300 – 2,700,000) 176,000 (90,000 – 266,000) 143,100 (75,000 – 200,800) 50,800 (30,000 – 71,300) 125,800 (50,800 – 229,300)
[1221.8 (110.9–4887.4)] [318.6 (162.9–481.5)] [259.0 (135.7–363.4)] [91.9 (54.3–129.1)] [227.7 (91.9–415.1)]
Sum (% of total costs) 98,623,800 (76.8) 58,582,300 (19.8) 34,941,300 (22.2) 16,374,500 (17.2) 208,521,900 (30.8)
[178,524.0] [106,042.8] [63,249.0] [29,640.3] [377,456.2]
Medication
Mean (SD) 188,200 (191,900) 332,800 (238,900) 291,100 (221,700) 166,100 (118,500) 258,000 (213,400)
[340.6 (347.3)] [602.4 (432.4)] [526.9 (401.3)] [300.7 (214.5)] [467.0 (386.3)]
Median (25th – 75th percentile) 127,900 (54,800 – 244,700) 277,300 (150,500 – 447,900) 258,500 (130,300 – 399,600) 136,800 (76,700 – 232,000) 210,600 (103,100 – 349,100)
[231.5 (99.2–442.9)] [501.9 (272.4–810.7)] [467.9 (235.8–723.3)] [247.6 (138.8–419.9)] [381.2 (186.6–631.9)]
Sum (% of total costs) 17,317,800 (13.5) 103,837,600 (35.1) 51,528,300 (32.7) 41,200,700 (43.2) 213,884,400 (31.6)
[31,347.8] [187,961.7] [93,274.0] [74,579.5] [387,163.1]
Hospitalization
Mean (SD) 32,400 (48,700) 173,100 (212,500) 240,500 (277,500) 44,900 (61,500) 131,300 (200,900)
[58.6 (88.2)] [313.3 (384.6)] [435.3 (502.3)] [81.3 (111.3)] [237.7 (363.6)]
Median (25th – 75th percentile) 8000 (4300 – 56,800) 104,100 (42,600 – 261,400) 127,800 (28,400 – 379,400) 26,700 (7000 – 71,000) 56,800 (11,000 – 161,500)
[14.5 (7.8–102.8)] [188.4 (77.1–473.2)] [231.3 (51.4–686.7)] [48.3 (12.6–128.5)] [102.8 (20.0–292.3)]
Sum (% of total costs) 2,982,100 (2.3) 52,613,900 (17.8) 39,195,000 (24.9) 11,144,400 (11.8) 105,935,400 (15.7)
[5398.0] [95,239.1] [70,948.9] [20,173.0] [191,759.1]
Physiotherapy
Mean (SD) 578,400 (503,000) 401,500 (368,900) 531,500 (475,900)
  [1047.0 (910.5)] [726.8 (667.7)]   [962.1 (861.4)]
Median (25th – 75th percentile) 408,500 (152,000 – 988,000) 342,000 (41,300 – 717,300) 389,500 (152,000 – 883,500)
  [739.4 (275.1–1788.4)] [619.1 (74.8–1298.4)]   [705.0 (275.1–1599.3)]
Sum (% of total costs) 41,645,500 (14.1) 10,438,500 (6.7) 52,084,000 (7.8)
   [75,384.6] [18,895.3]   [94,280.0]
Total Costs
Mean (SD) 1,395,200 (1,367,000) 932,700 (675,900) 815,400 (705,600) 384,300 (300,500) 796,100 (777,600)
[2525.5 (2474.5)] [1688.3 (1223.5)] [1476.0 (1277.2)] [695.6 (543.9)] [1441.0 (1407.6)]
Median (25th – 75th percentile) 773,400 (432,100 – 2,940,000) 797,000 (449,700 – 1,258,200) 611,600 (306,400 – 1,117,400) 298,100 (180,400 – 526,600) 571,500 (275,900 – 1,028,100)
[1400.0 (782.2–5321.8)] [1442.7 (814.0–2277.5)] [1107.1 (554.6–2022.6)] [539.6 (328.4–953.2)] [1034.5 (499.4–1861.0)]
Sum for each CVD and overall 128,357,700 295,662,600 157,370,700 95,303,300 676,694,300
[232,346.8] [535,194.0] [284,864.8] [172,513.4] [1,224,919.1]
% of total CVD costs combined 19.0 43.7 23.2 14.1 100.0
  1. Costs are in Central African francs (XAF). For ease with comprehension and comparisons, equivalent costs expressed in US dollars are presented in square brackets. CVD Cardiovascular disease, IHD Ischaemic heart disease, I-stroke Ischaemic stroke, H-stroke Haemorrhagic stroke, HHD Hypertensive heart disease, SD Standard deviation
\